Abigail Posner - 28 Feb 2023 Form 4 Insider Report for ENDI Corp. (ENDI)

Role: Director
Signature: /s/ David Sherman as Attorney-In-Fact for Abigail Posner
Issuer symbol: ENDI
Transactions as of: 28 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 02 Mar 2023, 15:47:50 UTC
Previous filing: 17 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENDI	Restricted Stock Units	Award	$0	+5.25K		$0.00	5.25K	28 Feb 2023	Class A Common Stock	5.25K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2	The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest immediately, in full, upon receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year.

Content

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

The restricted stock unit grant was approved by the Issuer's board of directors on February 28, 2023, subject to stockholder approval of the Issuer's 2022 Omnibus Equity Incentive Plan (the "Stockholder Approval") under which the restricted stock unit grant was awarded. The restricted stock units shall vest immediately, in full, upon receipt of Stockholder Approval. Notwithstanding the foregoing, if the Issuer's stockholders do not approve the 2022 Omnibus Equity Incentive Plan at the Issuer's 2023 annual stockholder meeting, the restricted stock unit grant shall be null and void. The restricted stock units shall be settled by the Issuer in the year following the year in which the applicable vesting date occurs, but no later than March 15 of such following year.